The role of p53 as a surrogate marker for chemotherapeutical responsiveness in ovarian cancer
2010
Introduction
In advanced ovarian cancers (OCs), p53 mutations are frequently observed. The objective of this study was to explore the value of the p53 mutational status, using four different techniques, in advanced OC patients as a predictive marker for responsiveness to platinum-based chemotherapy.
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
57
References
9
Citations
NaN
KQI